Skip to content

Parecoxib and paracetamol for pain relief following minor day stay gynaecological surgery (The PAINFREE Trial)

Early postoperative analgesia from parecoxib, paracetamol or both among patients having minor gynaecological sugery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000345987
Acronym
The PAINFREE Trial
Enrollment
240
Registered
2011-04-01
Start date
2011-04-19
Completion date
2012-08-14
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study objective is to compare the analgesic efficacy and quality of postoperative pain relief following minor gynaecological surgery between four different intra-operative analgesic regimens based on opioid plus either paracetamol, parecoxib, paracetamol and parecoxib in combination or placebo. The null hypothesis is that there is no difference in the analgesic efficacy and quality of pain relief provided by either paracetamol, parecoxib, paracetamol and parecoxib in combination or placebo in patients undergoing minor gynaecological surgery.

Interventions

Arm 1: single dose intraoperative intravenous parecoxib 40 mg Arm 2: single dose intraoperative intravenous paracetamol 2 g Arm 3: single dose intraoperative intravenous parecoxib 40 mg and intravenous paracetamol 2 g Arm 4: single dose intraoperative intravenous placebos This 2 x2 factorial design allows efficient evaluation of two treatments and in this case comparison not only of parecoxib versus placebo and paracetomol versus placebo but also the interaction of these two drugs (both versu

Arm 1: single dose intraoperative intravenous parecoxib 40 mg Arm 2: single dose intraoperative intravenous paracetamol 2 g Arm 3: single dose intraoperative intravenous parecoxib 40 mg and intravenous paracetamol 2 g Arm 4: single dose intraoperative intravenous placebos This 2 x2 factorial design allows efficient evaluation of two treatments and in this case comparison not only of parecoxib versus placebo and paracetomol versus placebo but also the interaction of these two drugs (both versus placebo) and evaluation of all patients receiving each drug eg. Arms 1 & 2 vs Arm 4 and Arms 2 & 3 vs Arm 4.

Sponsors

Women's and Newborn Health Service
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Factorial
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Dilatation and curettage American Society of Anesthesiologists physical status 1 or 2

Exclusion criteria

Renal dysfunction Hypertension Ischaemic heart disease Cerebrovascular disease Peptic ulcer or gastro-intestinal reflux disease Aspirin or nonsteroidal anti-inflammatory drug induced asthma Allergy to paracetamol, parecoxib or sulphonamides Hepatic dysfunction Taking analgesic drugs within 24 hours of surgery Unsuitable for anaesthesia with volatile anaesthetics or requiring intubation Prophylactic antiemetic therapy indicated

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 18, 2026